Thrombectomy 24 hours after stroke: beyond DAWN.
Shashvat M DesaiDiogo C HaussenAmin AghaebrahimAlhamza R Al-BayatiRoberta SantosRaul G NogueiraTudor G JovinAshutosh P JadhavPublished in: Journal of neurointerventional surgery (2018)
Thrombectomy appears to be safe and feasible in patients with acute ischemic stroke due to LVO meeting all DAWN trial criteria but treated beyond 24 hours of TLKW with outcomes comparable to patients in the DAWN trial intervention arm. Further studies are warranted to validate these findings.
Keyphrases
- acute ischemic stroke
- end stage renal disease
- newly diagnosed
- study protocol
- phase iii
- randomized controlled trial
- ejection fraction
- clinical trial
- phase ii
- prognostic factors
- chronic kidney disease
- peritoneal dialysis
- type diabetes
- adipose tissue
- insulin resistance
- open label
- metabolic syndrome
- weight loss
- glycemic control